Table 1.
Function of exosome mediated microRNA (miR) in cancer
Type of cancer | Exosome miR | Functions | References |
---|---|---|---|
Breast cancer | miR-100, miR-222, miR-125a-3p | Pathogenesis, diagnosis, chemo-resistance | [35,125,126] |
Leukemia | miR-146, miR-138, miR-203, miR-30a, 135-b, 196-b, 181-c | Autophagy, chemo-resistance | [3,127,128] |
Prostate and endometrial carcinoma | miR-204, miR-551b, 96, 183, 182, 153, 625, miR-141, 193b, 200c, 193a-3p, 205, 708, 365, 34a | Tumor development and progression, diagnosis | [56,129] |
Ovarian cancer | miR-21, miR-24 miR-141, miR-200a, miR-200b, miR 200c, miR-203, miR -205, and miR-214 | Diagnostic marker | [54,130] |
Pancreatic cancer | miR-203 | IL-12, TNF-α suppression | [98] |
Lung cancer, leukemia, head and neck cancer | miR-17-3p, 21, 106a, 146, 155, 191, 192, 203, 205, 210, 12, 214, 451 | Diagnostic marker, chemo-resistance | [131-134] |
Esophageal cancer | miR-21, miR221 | Tumor progression, chemo-resistance | [135,136] |
Lung cancer | miR-21 | Chemo-resistance | [137] |
Glioblastoma multiform | miR-9 | Temozolomide resistance | [46] |
Cervical cancer | miR-25 | Cisplatin resistance | [134] |
Gastric cancer | miR-20, miR-19b-3p, miR-106a-5p | Cisplatin resistance | [138] |
Liver cancer | miR-9-3p | Diagnosis biomarker | [65] |
Ovarian cancer | mir-21, miR-100 | Cell signaling | [139,140] |
Lung cancer | miR940, miR-23a | Tumorigenesis, intercellular communication | [141,142] |